We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
-12.49%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$48.6B
AUM Growth
-$4.2B
(-8%)
Cap. Flow
+$3.6B
Cap. Flow
% of AUM
7.4%
Top 10 Holdings %
Top 10 Hldgs %
10.29%
Holding
4,108
New
835
Increased
963
Reduced
740
Closed
743
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$340M |
| 2 |
Bank of America
BAC
|
+$302M |
| 3 |
Cigna
CI
|
+$294M |
| 4 |
TSMC
TSM
|
+$275M |
| 5 |
Union Pacific
UNP
|
+$256M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$426M |
| 2 |
S&P Global
SPGI
|
+$413M |
| 3 |
Booking.com
BKNG
|
+$264M |
| 4 |
Comcast
CMCSA
|
+$256M |
| 5 |
Teleflex
TFX
|
+$241M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.59% |
| 2 | Financials | 16.96% |
| 3 | Technology | 16.37% |
| 4 | Consumer Discretionary | 9.32% |
| 5 | Industrials | 7.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Comstock Resources
CRK
$3.94B
| $21.6M | 0.04% |
1,785,178
+1,761,375
| +7,400% | +$29.1M |
|
427
Sunrun
RUN
$2.46B
| $21.6M | 0.04% |
922,487
+55,589
| +6% | +$1.34M |
|
|
EA
428
DELISTED
Electronic Arts
EA
| $21.5M | 0.04% |
176,888
+90,101
| +104% | +$11.5M |
|
429
Trip.com Group
TCOM
$29.1B
| $21.5M | 0.04% |
+782,611
| New | +$17.5M |
|
430
Ciena
CIEN
$58.4B
| $21.4M | 0.04% |
468,223
-140,724
| -23% | -$7.3M |
|
431
United Microelectronic
UMC
$46.9B
| $21.3M | 0.04% |
3,148,141
+964,471
| +44% | +$7.91M |
|
432
WEX
WEX
$6.31B
| $21.2M | 0.04% |
136,576
+25,352
| +23% | +$4.15M |
|
433
Home Depot
HD
$355B
| $21.2M | 0.04% |
77,296
+50,695
| +191% | +$15M |
|
434
W.R. Berkley
WRB
$26.6B
| $21.1M | 0.04% |
+464,717
| New | +$21.1M |
|
435
Crocs
CROX
$6.55B
| $21.1M | 0.04% |
434,173
-312,052
| -42% | -$18.9M |
|
436
GoodRx Holdings
GDRX
$1.26B
| $21.1M | 0.04% |
3,567,491
-1,563
| -0% | -$17.4K |
|
|
NLSN
437
DELISTED
Nielsen Holdings plc
NLSN
| $21M | 0.04% |
905,329
+664,722
| +276% | +$17M |
|
438
StoneCo
STNE
$2.58B
| $21M | 0.04% |
2,726,467
+1,510,504
| +124% | +$14.5M |
|
439
Ultragenyx Pharmaceutical
RARE
$2.55B
| $21M | 0.04% |
351,650
-33,803
| -9% | -$2.08M |
|
440
First Majestic Silver
AG
$9.07B
| $21M | 0.04% |
2,920,647
+2,764,252
| +1,767% | +$27M |
|
441
Infosys
INFY
$50.7B
| $20.8M | 0.04% |
1,126,379
+1,071,770
| +1,963% | +$21.3M |
|
442
Tenable Holdings
TENB
$4.01B
| $20.8M | 0.04% |
458,778
+84,465
| +23% | +$4.35M |
|
|
CCV
443
DELISTED
Churchill Capital Corp V
CCV
| $20.7M | 0.04% |
2,106,730
+776,923
| +58% | +$7.64M |
|
|
ACQR
444
DELISTED
Independence Holdings Corp. Class A Ordinary Share
ACQR
| $20.6M | 0.04% |
2,098,759
+32,089
| +2% | +$314K |
|
|
AVAN
445
DELISTED
Avanti Acquisition Corp.
AVAN
| $20.6M | 0.04% |
2,077,320
| – | – |
|
446
PUT
VanEck Junior Gold Miners ETF
GDXJ
$8.46B
| $20.5M | 0.04% |
640,400
-281,500
| -31% | -$11.6M |
|
447
Trupanion
TRUP
$1.18B
| $20.5M | 0.04% |
340,011
+141,045
| +71% | +$9.6M |
|
448
Simon Property Group
SPG
$72.3B
| $20.4M | 0.04% |
215,159
-109,115
| -34% | -$12.5M |
|
449
Envoy Medical
COCH
$51.7M
| $20.4M | 0.04% |
2,080,871
| – | – |
|
450
NXP Semiconductors
NXPI
$60.4B
| $20.4M | 0.04% |
137,540
+82,913
| +152% | +$14.4M |
|
Similar funds
Marshall Wace's Q2 2022 Portfolio in Review
As of Q2 2022, Marshall Wace held 4,108 positions worth $48.6B, down 8% from $52.8B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Marshall Wace deployed $3.6B of net new capital in Q2 2022, opening 835 new positions and adding to 963 existing holdings. Its largest new stake was Eli Lilly: 1,133,393 shares worth $367M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Verizon, an estimated $426M trimmed.
- Marshall Wace's largest Q2 2022 buy was Eli Lilly: 1,133,393 shares worth $367M.
- Marshall Wace added most to Bank of America in Q2 2022, an estimated $302M increase.
- Marshall Wace's biggest Q2 2022 reduction was Verizon, cutting an estimated $426M.
- Marshall Wace fully exited Teleflex in Q2 2022, selling an estimated $241M.
- Marshall Wace's ten largest holdings make up 10% of its $48.6B portfolio in Q2 2022.
- Marshall Wace opened 835 new positions and closed 743 in Q2 2022.
- Marshall Wace's portfolio value fell 8% quarter-over-quarter to $48.6B.
Based on Marshall Wace's 13F filing for Q2 2022, filed 15 Aug 2022.